Why Shares of Amarin Corporation Dropped 46.1% in May
Copyright (c) 2022 Yahoo! Inc. All rights reserved.
sport
2022-06-01 23:08:03

Amarin Corporation (AMRN 0.00%), a biopharmaceutical company that specializes in cardiovascular therapies, saw its shares plummet 46.1% in May, according to data from S&P Global Market Intelligence. The stock closed at $2.69 a share on April 29, the last trading day of the month. It opened at $2.71 on Monday, May 2, then fell to a 52-week low of $1.11 on May 12, before rebounding a bit, closing out May at $1.45. For the year, the stock is down more than 56%.

Image source: Getty Images.

So what
The company has only one marketed therapy, Vascepa (icosapent ethyl), which is designed to reduce the risk of stroke or heart attack by lowering harmful triglycerides, a type of fat in your blood.
